Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI)
NASDAQ
Real-time Data
01:30 PM
Day's Range
7.2252 wk Range
2.54Overview - MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
1.43B
P/E (Trailing)
‪28.38‬
P/E (Forward)
‪-72.30‬
PEG Ratio
‪-0.40‬
Price / Sales (TTM)
‪13.48‬
Price / Book
‪5.53‬
EV / EBITDA
‪-72.48‬
Profitability
Gross Margin
‪40.14%‬
Profit Margin
‪-37.06%‬
Operating Margin
‪-29.39%‬
Return on Assets
‪-5.70%‬
Return on Equity
‪-33.04%‬
Ownership
Shares Outstanding
148.88M
Float
114.21M
Short % of Shares Outstanding
‪9.84%‬
Held by Insiders
‪7.25%‬
Held by Institutions
‪96.78%‬
Price stats
Beta
‪0.60‬
50-Day Avg
‪7.02‬
200-Day Avg
‪4.75‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
8 analysts
Average price target
‪$ 7.30‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock
Peers - MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- MRVINASDAQMaravai LifeSciences Holdings, Inc. Class A Common Stock2.81BMarket Cap+62.76%52-week change28.39P/E (Trailing)‪-37.06%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock
About
Maravai LifeSciences Holdings, Inc. Class A Common Stock represents ownership in Maravai LifeSciences Holdings, Inc., a life sciences company focused on products and services that support drug development, vaccine creation, cell and gene therapy research, and diagnostics. The company serves biopharmaceutical,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
